Device Trial Radar · NCT04920929
PICC Asymptomatic Thrombosis Study: A Pilot Study
Last checked: Nov 20, 2026Latest source record: Nov 29, 2022 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Terminated
Enrollment
7
Actual
Start
Jul 15, 2021
Primary completion
Oct 7, 2021
Study completion Oct 7, 2021
Sponsor
- Lead sponsor
- Access Vascular IncNot on our public-company list
- Sponsor type
- Industry
- First posted
- Jun 10, 2021
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Other
- FDA-regulated device
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The study purpose is to perform a preliminary, comparative evaluation of the Hydrophilic Biomaterial technology to confirm the performance of the catheter, by using UltraSound technology in-vivo.
Conditions
- Peripheral ICC
Interventions
Hydrophilic BiomaterialDevice
PICC made out of a Hydrophilic Biomaterial
Thermoplastic PolyurethaneDevice
PICC made out of a thermoplastic polyurethane material
Primary outcomes
What the sponsor says the trial is designed to measure.
- Asymptomatic Thrombosis RateTime frame: 7 days post insertion
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Beaumont Hospital
Royal Oak, Michigan
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.